Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 12 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 2 (2)
P 3 (1)

Trial Status

Completed9
Unknown3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (12)

Research Network

Activity Timeline